What is Amgen's change in other liabilities?

Amgen (AMGN) reported change in other liabilities of -$75M in Q1 2026.

How has Amgen's change in other liabilities changed year-over-year?

Amgen's change in other liabilities increased by 3.8% year-over-year, from -$78M to -$75M.

What is the long-term trend for Amgen's change in other liabilities?

Over 3 years (2021 to 2025), Amgen's change in other liabilities has grown at a 50.6% compound annual growth rate (CAGR), from -$48M to -$164M.

What does change in other liabilities mean?

Change in miscellaneous liabilities affecting operating cash flow.

Amgen AMGN Change in Other Liabilities

Change in Other Liabilities at other companies

PfizerPFE

-$916.75M-17.7%

Oruka Therapeutics, Inc.ORKA

-$493K-694%

Jazz PharmaceuticalsJAZZ

$12.2M+321%

Cogent Biosciences, Inc.COGT

$29K+480%

Revolution Medicines, Inc.RVMD

$5.66M+63.3%

Roivant SciencesROIV

-$252K-230%

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$195.44B+34.6%

Enterprise value$252.2B+25.7%

P/E25.1×+3.1×

P/S5.3×+1.1×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's change in other liabilities?: Amgen (AMGN) reported change in other liabilities of -$75M in Q1 2026.
How has Amgen's change in other liabilities changed year-over-year?: Amgen's change in other liabilities increased by 3.8% year-over-year, from -$78M to -$75M.
What is the long-term trend for Amgen's change in other liabilities?: Over 3 years (2021 to 2025), Amgen's change in other liabilities has grown at a 50.6% compound annual growth rate (CAGR), from -$48M to -$164M.
What does change in other liabilities mean?: Change in miscellaneous liabilities affecting operating cash flow.